54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 08
11:28 UTC
|
EXPE
Expedia Group
|
◎ Target | Ken Gawrelski ★★★☆☆ #1080 | Equal Weight | $303.00→ $307.00+1.3% |
|
Aug 08
11:28 UTC
|
EXPE
Expedia Group
|
◎ Target | Shyam Patil ★★★☆☆ #1208 | Neutral | $250.00→ $315.00+26.0% |
|
Aug 08
11:28 UTC
|
EVMN
Evommune
|
◎ Target | Brian Abrahams ★★★☆☆ #1865 | Outperform | $30.00→ $29.00-3.3% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Stephen Ju ★★☆☆☆ #2324 | Neutral | $74.00→ $86.00+16.2% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Ronald Josey ★★★☆☆ #2149 | Neutral | $60.00→ $92.00+53.3% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Steven Forbes ★★★★☆ #412 | Buy | $85.00→ $95.00+11.8% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Trevor Young ★★★★☆ #901 | Overweight | $82.00→ $94.00+14.6% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1736 | Neutral | $80.00→ $85.00+6.2% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Bernie McTernan ★★☆☆☆ #2560 | Buy | $85.00→ $100.00+17.6% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Ken Gawrelski ★★★☆☆ #1080 | Underweight | $61.00→ $76.00+24.6% |
|
Aug 08
11:28 UTC
|
ETSY
Etsy
|
◎ Target | Anna Andreeva ★★★☆☆ #1277 | Neutral | $70.00→ $80.00+14.3% |
|
Aug 08
11:28 UTC
|
ESTA
Establishment Labs
|
◎ Target | Allen Gong ★★★★☆ #553 | Overweight | $84.00→ $95.00+13.1% |
|
Aug 08
11:28 UTC
|
ERO
Ero Copper
|
◎ Target | firm only | Hold | C$44.00→ C$45.00+2.3% |
|
Aug 08
11:28 UTC
|
ERO
Ero Copper
|
◎ Target | firm only | Outperform | C$50.00→ C$52.50+5.0% |
|
Aug 08
11:28 UTC
|
EPR
EPR Properties
|
◎ Target | Michael Carroll ★★★★☆ #894 | Sec→ r Perform | $61.00→ $64.00+4.9% |
|
Aug 08
11:28 UTC
|
EPC
Edgewell Personal Care
|
◎ Target | Lauren Lieberman ★★★☆☆ #1047 | Equal Weight | $28.00→ $29.00+3.6% |
|
Aug 08
11:28 UTC
|
EPAM
EPAM Systems
|
◎ Target | Puneet Jain ★★★★★ #319 | Overweight | $142.00→ $120.00-15.5% |
|
Aug 08
11:28 UTC
|
EPAM
EPAM Systems
|
◎ Target | James Friedman ★★★☆☆ #1635 | Positive | $167.00→ $146.00-12.6% |
|
Aug 08
11:28 UTC
|
EPAM
EPAM Systems
|
◎ Target | Arvind Ramnani ★★★☆☆ #2214 | Hold | $112.00→ $110.00-1.8% |
|
Aug 08
11:28 UTC
|
EPAM
EPAM Systems
|
◎ Target | Bryan Bergin ★★★★★ #283 | Buy | $131.00→ $120.00-8.4% |
|
Aug 08
11:28 UTC
|
ENR
Energizer
|
◎ Target | Peter Grom ★★★★★ #277 | Neutral | $21.00→ $23.00+9.5% |
|
Aug 08
11:28 UTC
|
ENOV
Enovis
|
◎ Target | Larry Biegelsen ★★★★☆ #764 | Overweight | $40.00→ $39.00-2.5% |
|
Aug 08
11:28 UTC
|
EHC
Encompass Health
|
◎ Target | A.J. Rice ★★★★☆ #410 | Buy | $150.00→ $155.00+3.3% |
|
Aug 08
11:28 UTC
|
EHC
Encompass Health
|
◎ Target | David MacDonald not yet tracked | Buy | $140.00→ $150.00+7.1% |
|
Aug 08
11:28 UTC
|
EFX
Enerflex
|
◎ Target | firm only | Outperform | C$47.00→ C$48.00+2.1% |
|
Aug 08
11:28 UTC
|
ED
Consolidated Edison
|
◎ Target | Shahriar Pourreza ★★★☆☆ #1577 | Equal Weight | $106.00→ $108.00+1.9% |
|
Aug 08
11:28 UTC
|
ED
Consolidated Edison
|
◎ Target | Nicholas Campanella ★★★☆☆ #1702 | Underweight | $112.00→ $106.00-5.4% |
|
Aug 08
11:28 UTC
|
DXPE
DXP Enterprises
|
◎ Target | Tommy Moll ★★★☆☆ #1095 | Overweight | $160.00→ $220.00+37.5% |
|
Aug 08
11:28 UTC
|
DVA
DaVita
|
◎ Target | David MacDonald not yet tracked | Hold | $250.00→ $215.00-14.0% |
|
Aug 08
11:28 UTC
|
DUOL
Duolingo
|
◎ Target | Alec Brondolo ★★★☆☆ #1436 | Underweight | $82.00→ $80.00-2.4% |
|
Aug 08
11:28 UTC
|
DRVN
Driven Brands
|
◎ Target | Steven Shemesh ★★★★☆ #817 | Outperform | $17.00→ $16.00-5.9% |
|
Aug 08
11:28 UTC
|
DOCS
Doximity
|
◎ Target | Alexei Gogolev ★★★★☆ #890 | Neutral | $26.00→ $31.00+19.2% |
|
Aug 08
11:28 UTC
|
DNOW
DNOW
|
◎ Target | Charles Minervino ★★☆☆☆ #2406 | Positive | $16.00→ $19.00+18.8% |
|
Aug 08
11:28 UTC
|
DNLI
Denali Therapeutics
|
◎ Target | Michael Yee ★★★☆☆ #1045 | Buy | $25.00→ $34.00+36.0% |
|
Aug 08
11:28 UTC
|
DKNG
DraftKings
|
◎ Target | Mike Hickey ★★☆☆☆ #2756 | Buy | $29.00→ $30.00+3.4% |
|
Aug 08
11:28 UTC
|
DII.B
Dorel Industries
|
◎ Target | firm only | Hold | C$2.00→ C$1.50-25.0% |
|
Aug 08
11:28 UTC
|
DEI
Douglas Emmett
|
◎ Target | Richard Anderson ★★★☆☆ #1425 | Neutral | $12.00→ $13.00+8.3% |
|
Aug 08
11:28 UTC
|
DDOG
Datadog
|
◎ Target | Karl Keirstead ★★★☆☆ #1049 | Buy | $315.00→ $280.00-11.1% |
|
Aug 08
11:28 UTC
|
DDOG
Datadog
|
◎ Target | Mike Cikos ★★★★★ #100 | Buy | $260.00→ $300.00+15.4% |
|
Aug 08
11:28 UTC
|
DDOG
Datadog
|
◎ Target | Fatima Boolani ★★★★★ #214 | Buy | $300.00→ $305.00+1.7% |
|
Aug 08
11:28 UTC
|
DD
DuPont de Nemours
|
◎ Target | Arun Viswanathan ★★★☆☆ #1225 | Outperform | $180.00→ $176.00-2.2% |
|
Aug 08
11:28 UTC
|
DCO
Ducommun
|
◎ Target | Ken Herbert not yet tracked | Sec→ r Perform ➝ Sector Performer | $175.00→ $200.00+14.3% |
|
Aug 08
11:28 UTC
|
DBX
Dropbox
|
◎ Target | Steven Enders not yet tracked | Neutral | $28.00→ $33.00+17.9% |
|
Aug 08
11:28 UTC
|
DASH
DoorDash
|
◎ Target | Shyam Patil ★★★☆☆ #1208 | Positive | $225.00→ $250.00+11.1% |
|
Aug 08
11:28 UTC
|
DASH
DoorDash
|
◎ Target | Ken Gawrelski ★★★☆☆ #1080 | Equal Weight | $199.00→ $225.00+13.1% |
|
Aug 08
11:28 UTC
|
DAN
Dana
|
◎ Target | Colin Langan ★★☆☆☆ #2548 | Equal Weight | $33.00→ $28.00-15.2% |
|
Aug 08
11:28 UTC
|
DAN
Dana
|
◎ Target | Joseph Spak ★★★☆☆ #1824 | Buy | $39.00→ $38.00-2.6% |
|
Aug 08
11:28 UTC
|
DAN
Dana
|
◎ Target | Tom Narayan ★★★☆☆ #1674 | Outperform | $33.00→ $37.00+12.1% |
|
Aug 08
11:28 UTC
|
CYTK
Cytokinetics
|
◎ Target | Leonid Timashev ★★★☆☆ #1437 | Outperform | $117.00→ $112.00-4.3% |
|
Aug 08
11:28 UTC
|
CYTK
Cytokinetics
|
◎ Target | Jason N. Butler not yet tracked | Market Outperform | $105.00→ $110.00+4.8% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.